IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 196 filers reported holding IMPAX LABORATORIES INC in Q1 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $607,000 | +7.2% | 29,900 | -30.0% | 0.02% | +15.0% |
Q4 2016 | $566,000 | -54.6% | 42,700 | -1.4% | 0.02% | -52.4% |
Q2 2016 | $1,248,000 | +78.0% | 43,300 | +97.7% | 0.04% | +100.0% |
Q1 2016 | $701,000 | +38.3% | 21,900 | +36.9% | 0.02% | +16.7% |
Q4 2014 | $507,000 | -15.8% | 16,000 | -45.6% | 0.02% | -67.3% |
Q3 2013 | $602,000 | -19.9% | 29,400 | -22.0% | 0.06% | -28.6% |
Q2 2013 | $752,000 | – | 37,700 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 730,817 | $21,062,000 | 7.59% |
Hound Partners | 6,757,558 | $194,753,000 | 5.18% |
Aravt Global | 2,232,500 | $64,341,000 | 4.78% |
Asymmetry Capital Management, L.P. | 70,235 | $2,024,000 | 3.71% |
UNIVERSITY OF NOTRE DAME DU LAC | 66,091 | $1,905,000 | 1.80% |
Orbimed Advisors | 5,886,700 | $169,655,000 | 1.77% |
Pennant Capital Management, LLC | 1,949,569 | $56,187,000 | 1.44% |
SECTOR GAMMA AS | 233,934 | $6,742,000 | 1.28% |
Tygh Capital Management, Inc. | 137,190 | $3,954,000 | 1.11% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 555,086 | $15,998,000 | 0.93% |